Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Sales (2016 - 2025)

Historic Return on Sales for Anaptysbio (ANAB) over the last 10 years, with Q3 2025 value amounting to 0.2%.

  • Anaptysbio's Return on Sales rose 12900.0% to 0.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56%, marking a year-over-year increase of 23400.0%. This contributed to the annual value of 1.59% for FY2024, which is 79500.0% up from last year.
  • Latest data reveals that Anaptysbio reported Return on Sales of 0.2% as of Q3 2025, which was up 12900.0% from 1.74% recorded in Q2 2025.
  • Over the past 5 years, Anaptysbio's Return on Sales peaked at 0.2% during Q3 2025, and registered a low of 32.38% during Q1 2022.
  • In the last 5 years, Anaptysbio's Return on Sales had a median value of 4.43% in 2022 and averaged 9.72%.
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -313100bps in 2021, then soared by 263200bps in 2022.
  • Quarter analysis of 5 years shows Anaptysbio's Return on Sales stood at 30.75% in 2021, then soared by 86bps to 4.43% in 2022, then decreased by -6bps to 4.69% in 2023, then surged by 81bps to 0.87% in 2024, then soared by 123bps to 0.2% in 2025.
  • Its Return on Sales stands at 0.2% for Q3 2025, versus 1.74% for Q2 2025 and 1.42% for Q1 2025.